EQUITY RESEARCH MEMO

Analytical Services International

Generated 5/10/2026

Executive Summary

Conviction (model self-assessment)65/100

Analytical Services International (ASI) is a well-established bioanalysis and toxicology laboratory based in London, UK, with over three decades of experience since its founding in 1990. Accredited under ISO/IEC 17025:2017 and compliant with MHRA GLP and GCP standards, ASI provides high-quality forensic toxicology, clinical trial bioanalysis, therapeutic drug monitoring, and expert witness services. Leveraging advanced mass spectrometry and deep scientific expertise, the lab delivers accurate, interpreted data to a diverse client base including coroners, law enforcement, pharmaceutical companies, and healthcare providers. Its strong reputation and regulatory compliance position it as a trusted partner in the UK diagnostics and life sciences ecosystem. With a focus on precision and reliability, ASI continues to serve critical roles in both public health and criminal justice contexts.

Upcoming Catalysts (preview)

  • Q3 2026New multi-year contract with a major pharmaceutical company for clinical trial bioanalysis40% success
  • Q4 2026Expansion of service offerings into emerging therapeutic areas (e.g., biologics, gene therapy)30% success
  • Q1 2027Implementation of updated MHRA GLP guidelines potentially increasing demand for independent lab services50% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)